These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8464807)

  • 1. Drug release mechanism from a microcrystalline cellulose pellet system.
    O'Connor RE; Schwartz JB
    Pharm Res; 1993 Mar; 10(3):356-61. PubMed ID: 8464807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug release from a multiparticulate pellet system.
    Zimm KR; Schwartz JB; O'Connor RE
    Pharm Dev Technol; 1996 Apr; 1(1):37-42. PubMed ID: 9552329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
    Heng PW; Koo OM
    Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose.
    Basit AW; Newton JM; Lacey LF
    Pharm Dev Technol; 1999; 4(4):499-505. PubMed ID: 10578503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D; Kleinebudde P
    Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to developing fast release pellets via wet extrusion-spheronization.
    Xia Y; Shi CY; Fang JG; Wang WQ
    Pharm Dev Technol; 2018 Jun; 23(5):432-441. PubMed ID: 27882815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro behavior of dronedarone hydrochloride loaded pellets using vacuum impregnation technique.
    Gretić M; Štanfel M; Barbarić J; Rimac N; Matijašić G
    Eur J Pharm Biopharm; 2021 May; 162():70-81. PubMed ID: 33727144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.
    Gómez-Carracedo A; Souto C; Marti Nez-Pacheco R; Concheiro A; Gómez-Amoza JL
    Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alginate-based pellets prepared by extrusion/spheronization: effect of the amount and type of sodium alginate and calcium salts.
    Sriamornsak P; Nunthanid J; Luangtana-anan M; Weerapol Y; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):274-84. PubMed ID: 17962003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of polyethylene glycol and superdisintegrant on dissolution rate enhancement of simvastatin in pellet formulation.
    Afrasiabi Garekani H; Aftabi SF; Nia FF; Javidi M; Nokhodchi A; Sadeghi F
    Pharm Dev Technol; 2019 Jul; 24(6):720-728. PubMed ID: 30776937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV; Gu L; Soh JL; Heng PW
    Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of microcrystalline cellulose II (MCCII) as an alternative extrusion-spheronization aid.
    Rojas J; Kumar V
    Pharmazie; 2012 Jul; 67(7):595-7. PubMed ID: 22888514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
    AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P; Steffens KJ; Kleinebudde P
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures.
    Kleinebudde P; Schröder M; Schultz P; Müller BW; Waaler T; Nymo L
    Pharm Dev Technol; 1999 Aug; 4(3):397-404. PubMed ID: 10434285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.